Danaparoid

Danaparoid is an anticoagulant medication that is used to prevent and treat thrombosis. It is a mixture of heparan sulfate, dermatan sulfate, and chondroitin sulfate, which are all glycosaminoglycans. Danaparoid is marketed under the brand name Orgaran.

Mechanism of Action

Danaparoid works by inhibiting factor Xa, a protein involved in blood clotting. It does this by enhancing the activity of antithrombin, a protein that inhibits factor Xa. This prevents the formation of blood clots.

Uses

Danaparoid is used to prevent and treat deep vein thrombosis (DVT) and pulmonary embolism (PE). It is also used in the treatment of heparin-induced thrombocytopenia (HIT).

Side Effects

Common side effects of danaparoid include bleeding, anemia, and thrombocytopenia. Rare but serious side effects include allergic reactions, osteoporosis, and heparin-induced thrombocytopenia (HIT).

Contraindications

Danaparoid should not be used in people with active bleeding or a history of heparin-induced thrombocytopenia (HIT). It should also not be used in people with severe kidney disease.

Interactions

Danaparoid may interact with other anticoagulants, increasing the risk of bleeding. It may also interact with certain medications used to treat heart disease and high blood pressure.

Dosage

The dosage of danaparoid depends on the condition being treated and the patient's weight. It is usually given as an injection under the skin.

See Also

• Anticoagulant
• Deep vein thrombosis
• Pulmonary embolism
• Heparin-induced thrombocytopenia

Danaparoid Resources
Latest articles Most recent articles Ongoing trials	Wikipedia